Adora Animal Health

Adora Animal Health is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for companion animals, specifically dogs and cats. Founded by industry veterans with extensive experience at Aratana Therapeutics and Zoetis, the company focuses on identifying proven human drug candidates and optimizing them for veterinary use. Their development strategy leverages a capital-efficient "human-to-animal" translation model to address significant unmet needs in pet medicine. The company's pipeline primarily targets chronic pain management and inflammatory diseases. In October 2023, Adora Animal Health was acquired by Dechra Pharmaceuticals to enhance Dechra's specialty pipeline and drive long-term growth in the companion animal market.